Barriers to antiretroviral medication adherence in HIV-infected women.
about
Impact of individual-level social capital on quality of life among AIDS patients in ChinaAdherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsA systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA.Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactionsPrevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States.Bayesian data augmentation methods for the synthesis of qualitative and quantitative research findings.HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited CohortsGender differences in factors associated with adherence to antiretroviral therapy.Understanding the psychosocial needs of HIV-infected children and families: a qualitative study.Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time.How qualitative methods contribute to understanding combination antiretroviral therapy adherence.Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE studyReasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi.Adherence to HAART among patients with HIV: breakthroughs and barriers.Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug usersFactors associated with retention and viral suppression among a cohort of HIV+ women of color.Factors Supporting and Inhibiting Adherence to HIV Medication Regimen in Women: A Qualitative Analysis of Patient Interviews.Cognitive reorganization and stigmatization among persons with HIV.Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature.Research results have expiration dates: ensuring timely systematic reviews.Using qualitative metasummary to synthesize qualitative and quantitative descriptive findings.Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced patients with HIV type 1 infectionParticipant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.Stages of change for adherence to antiretroviral medications.A Bayesian method for the synthesis of evidence from qualitative and quantitative reports: the example of antiretroviral medication adherence.Transforming verbal counts in reports of qualitative descriptive studies into numbersThe influence of personal communities on the self-management of medication taking: A wider exploration of medicine work.Response to combined antiretroviral therapy according to gender and origin in a cohort of naïve HIV-infected patients: GESIDA-5808 study.HIV and tuberculosis in Durban, South Africa: adherence to two medication regimens.Intentionality of medication non-adherence among individuals living with HIV/AIDS in Hong Kong.The Role of Emotional Avoidance, the Patient-Provider Relationship, and Other Social Support in ART Adherence for HIV+ Individuals.Investigating the psychosocial impact of anti-HIV combination therapies.Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial.Are social support and HIV coping strategies associated with lower depression in adults on antiretroviral treatment? Evidence from rural KwaZulu-Natal, South Africa.Perceived social support and HIV/AIDS medication adherence among African American women.Exploring tuberculosis patients' adherence to treatment regimens and prevention programs at a public health site.Prevalence and Factors Associated with Fixed-Dose Combination Antiretroviral Drugs Adherence among HIV-Positive Pregnant Women on Option B Treatment in Mpumalanga Province, South Africa.Prediction of adherence to antiretroviral therapy: a one-year longitudinal study.Reframing HIV adherence as part of the experience of illness.
P2860
Q25017375-F633B370-2A8D-4AF6-9D79-2226057A651EQ28469073-20A38A9B-B261-4EED-AB5A-D9646D7DD1D4Q33553219-608A1AA4-021D-42C5-A67F-ECF7DD7F5F29Q33797229-3F3EEE61-1B27-40D3-AF40-F3DA1E0E8DA2Q33810815-FBA122DC-69AF-4EDD-B843-ED0417E16C32Q33900274-259AE2B1-8E35-4BFF-9C01-4ED22884AE3BQ33907350-1FDC6430-56FA-480C-880F-24D34F6B2D9AQ33938482-DF9206A0-3A56-488F-BA0F-015138A0D4E1Q34140490-6AED6C0D-93FB-45F0-854D-9318E85F1491Q34373751-46083B65-69DF-4719-8A91-8080F466568EQ34438311-931C98F4-6407-473C-BF49-FAF8B5D289ADQ34481365-B1FA2913-F57D-40AB-BFD9-072A7729ED65Q34493306-3D5651A0-3B05-40D5-9D2E-0AA7ACE14CF9Q34664263-84A0AA3D-866B-45FF-AFE4-705E695C05A5Q34743004-E7BC8080-A83F-4779-B3AC-45069DC6868CQ34811406-313AE36F-67EF-4150-BD39-E0C7A9EC49B6Q35790378-727BE2AA-DDE5-47D9-8D14-07A92B60E719Q35863349-5C4503F3-4E96-4300-9824-60AD2C208118Q36057261-F67FEBF5-86BF-43E5-B5E3-9E759141E14AQ36565091-AA7AC540-D08D-43D0-AF99-63429A524CCFQ36579708-03100FDE-DE21-44EA-A5F1-84A0170C7B51Q36833521-54D2AE42-5F66-4EAB-8D62-DF57A907B6ABQ36974067-52FD4E04-3E01-473F-939A-0B1A775F75C2Q37216377-9F82900F-6C1C-4CE0-BC53-62E0EC31C364Q37216407-7A24B143-B310-4FB2-945E-1E2B4B0D7508Q37394337-3F4A4998-DC46-461A-A5F1-E8226D7B9FBBQ37442243-031E6575-1D68-4025-9F00-3AD3E8AA8E0DQ39177109-415FD238-57C9-434F-8DCE-C78ADDE5AA12Q39372748-EB05C981-F632-4402-8B64-377C0150BFD0Q39917397-0BDC347A-79DB-444B-BFBF-38780BC6E466Q39941362-4CE58A60-840A-452E-967C-CA81B8FFEAFAQ40305836-A8E639CC-EC29-4B86-85C3-BD18E94D6B7EQ40612542-B61A8927-49B0-4909-B26C-584E42AA695DQ46715020-AAABDE68-624F-49F6-BEF3-1E03F9D8D387Q46745806-808152F7-660B-46BC-9F33-4DF095EA5AB6Q46887011-91C501D0-E11E-4A33-8662-553A6C9E282CQ47336488-1CDE97F2-6538-4791-9306-AD78488E7688Q47555283-6EF5EBCD-318B-4484-AD7F-0F964F5DBDE7Q48480671-A4922E03-B971-4F44-8DAF-8CF3D6235DB3Q50111278-65E02ED2-77B8-4EB1-B298-AFB030108187
P2860
Barriers to antiretroviral medication adherence in HIV-infected women.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Barriers to antiretroviral medication adherence in HIV-infected women.
@en
Barriers to antiretroviral medication adherence in HIV-infected women.
@nl
type
label
Barriers to antiretroviral medication adherence in HIV-infected women.
@en
Barriers to antiretroviral medication adherence in HIV-infected women.
@nl
prefLabel
Barriers to antiretroviral medication adherence in HIV-infected women.
@en
Barriers to antiretroviral medication adherence in HIV-infected women.
@nl
P1433
P1476
Barriers to antiretroviral medication adherence in HIV-infected women.
@en
P2093
P304
P356
10.1080/09540120050123774
P577
2000-08-01T00:00:00Z